ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 142,85
0,83%
Dow Jones
38 874,40
-0,03%
DAX
18 483,74
0,25%
Brent Oil
82,525
-0,41%
Bitcoin
62 287,87
-0,06%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Impel Pharmaceuticals Inc (IMPL)

  7. Impel Pharmaceuticals Inc (IMPL) Actualités

IMPL

Impel Pharmaceuticals (IMPL)

Impel Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:IMPL
DateHeureSourceTitreSymboleSociété
09/04/202422h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMPLImpel Pharmaceuticals Inc
16/02/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:IMPLImpel Pharmaceuticals Inc
14/02/202423h21Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:IMPLImpel Pharmaceuticals Inc
14/02/202423h16Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:IMPLImpel Pharmaceuticals Inc
14/02/202423h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMPLImpel Pharmaceuticals Inc
26/12/202322h32Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IMPLImpel Pharmaceuticals Inc
05/10/202323h19Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IMPLImpel Pharmaceuticals Inc
05/10/202314h00GlobeNewswire Inc.Impel Pharmaceuticals Announces Exploration of Strategic AlternativesNASDAQ:IMPLImpel Pharmaceuticals Inc
18/08/202315h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IMPLImpel Pharmaceuticals Inc
15/08/202322h29Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:IMPLImpel Pharmaceuticals Inc
05/07/202316h05AllPennyStocks.comBiotech Catches Major Premarket BidNASDAQ:IMPLImpel Pharmaceuticals Inc
21/06/202312h00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMPLImpel Pharmaceuticals Inc
15/06/202314h00GlobeNewswire Inc.Impel Pharmaceuticals to Present New Real-World Data for Trudhesa® at the 65th Annual Scientific Meeting of the American Headache SocietyNASDAQ:IMPLImpel Pharmaceuticals Inc
12/05/202322h23Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:IMPLImpel Pharmaceuticals Inc
12/05/202317h23Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:IMPLImpel Pharmaceuticals Inc
12/05/202314h00GlobeNewswire Inc.Impel Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:IMPLImpel Pharmaceuticals Inc
10/05/202314h11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMPLImpel Pharmaceuticals Inc
10/05/202314h00GlobeNewswire Inc.Impel Pharmaceuticals Announces Appointment of Michael W. Kalb as Chief Financial OfficerNASDAQ:IMPLImpel Pharmaceuticals Inc
05/05/202314h00GlobeNewswire Inc.Impel Pharmaceuticals to Report First Quarter 2023 Financial Results on Friday, May 12, 2023NASDAQ:IMPLImpel Pharmaceuticals Inc
27/04/202322h10Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:IMPLImpel Pharmaceuticals Inc
27/04/202322h09Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:IMPLImpel Pharmaceuticals Inc
26/04/202314h00GlobeNewswire Inc.Impel Pharmaceuticals Presents New Data at AAN 2023 Suggesting Trudhesa® Nasal Spray is Safe to Use When Co-Administered With Commonly Prescribed Migraine MedicationsNASDAQ:IMPLImpel Pharmaceuticals Inc
14/04/202322h12Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:IMPLImpel Pharmaceuticals Inc
12/04/202322h01GlobeNewswire Inc.Impel Pharmaceuticals Announces Appointment of Darren Cline to the Board of DirectorsNASDAQ:IMPLImpel Pharmaceuticals Inc
11/04/202314h00GlobeNewswire Inc.Impel Pharmaceuticals to Present Data on Trudhesa® Nasal Spray for Treatment of Acute Migraine at 2023 American Academy of Neurology Annual MeetingNASDAQ:IMPLImpel Pharmaceuticals Inc
31/03/202322h32Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:IMPLImpel Pharmaceuticals Inc
24/03/202313h17GlobeNewswire Inc.Impel Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business UpdateNASDAQ:IMPLImpel Pharmaceuticals Inc
17/03/202313h00GlobeNewswire Inc.Impel Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on Friday, March 24, 2023NASDAQ:IMPLImpel Pharmaceuticals Inc
03/03/202322h01GlobeNewswire Inc.Impel Pharmaceuticals to Participate in Upcoming Investor Conferences in MarchNASDAQ:IMPLImpel Pharmaceuticals Inc
22/02/202322h30GlobeNewswire Inc.Impel Pharmaceuticals Announces Strategic Repriortization, Continues Focus on Maximizing Trudhesa® Commercial OpportunityNASDAQ:IMPLImpel Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:IMPL

Dernières Valeurs Consultées

EU
SGO
Cie de SaintGobain
EU
VK
Vallourec
NASDAQ
AAPL
Apple
NYSE
DIS
Walt Disney
EU
BN
Danone
EU
DG
Vinci
COIN
ETHUSD
Ethereum
NYSE
MCD
McDonalds
EU
CAP
Capgemini
EU
CS
Axa
EU
PX1
CAC 40
COIN
BTCUSD
Bitcoin
NYSE
JPM
JP Morgan Chase
EU
PX4
SBF 120
EU
BNP
BNP Paribas
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés